Antimicrobials and anti-infection agents shape a noteworthy share of the animalantibiotics and antimicrobials market. At present, the worldwide antimicrobials and anti-infection agents market is driven by the developing need to protect animal wellbeing attributable to rising interest for animal proteins over the globe, and developing interest in the sidekick creatures portion. Developing domesticated animal’s populace, expanding occurrences of illness episodes and increment in the sidekick creature possession are a portion of the elements driving the development of this market to a specific degree. Other than the auxiliary market drivers, there are solid geographic drivers for the development of the animal antimicrobials and anti-infection agents showcase. The developing markets are turning out to be progressively appealing.

    The Animal Antibiotics and Antimicrobials Market is expected to exceed more than US$ 4.73 Billion by 2022 at a CAGR of 4.6% in the given forecast period.

    This report provides:

    1) An overview of the global market for Antibiotics and Antimicrobials Market and related technologies.
    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
    3) Identifications of new market opportunities and targeted promotional plans Antibiotics and Antimicrobials Market .
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    You Can Find Full Report @:

    The major driving factors of Animal Antibiotics and Antimicrobials Market are as follows:

    • Animal based food products demands are in raise
    • Growing interest for pet protection and animal wellbeing expenditure
    • Increasing occurrences of zoonotic infections

    The restraining factors of Animal Antibiotics and Antimicrobials Market are as follows:

    • Lack of innovative of new antibiotic
    • Growing imperviousness to antimicrobials and anti-microbials

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Inc. (U.S.), Merck & Co.,Zoetis, Inc. (U.S.), Bayer AG (Germany), Eli Lilli and Company (U.S.), Virbac (France), Sanofi (France), BoehringerIngelheim GmbH (Germany), Vetoquinol S.A. (France), CevaSanteAnimale (France), and Dechra Pharmaceuticals PLC (U.K.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.


    Table of Contents


    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    5 Market Overview

    6 Industry Insights

    7 Animal Antimicrobials and Antibiotics Market, By Product

    7.1 Introduction
    7.2 Tetracyclines
    7.3 Penicillins
    7.4 Sulfonamides
    7.5 Macrolides
    7.6 Aminoglycosides
    7.7 Lincosamides
    7.8 Fluoroquinolones
    7.9 Cephalosporins
    7.1 Other Antimicrobials and Antibiotics

    8 Animal Antimicrobials and Antibiotics Market, By Mode of Delivery

    9 Animal Antimicrobials and Antibiotics Market, By Type of Animal

    10 Animal Antimicrobials and Antibiotics Market, By Region

    11 Competitive Landscape

    12 Company Profiles

    12.1 Introduction

    12.2 Zoetis, Inc.

    12.3 Boehringer Ingelheim GmbH

    12.4 Eli Lilly and Company

    12.5 Merck & Co., Inc.

    12.6 Bayer AG

    12.7 Sanofi

    12.8 Ceva Sante Animale

    12.9 Virbac

    12.10 Vetoquinol S.A.

    12.11 Dechra Pharmaceuticals PLC


    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay


    Phone: +1-855-984-1862

    Country: United States